(Q57780536)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

(11)C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Andrei Fodor

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Cinzia Crivellaro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Claudio Fiorino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Margarita Kirienko

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Elena Incerti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

G Berardi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

E Busnardo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

G Giovacchini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

C Messa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

L Gianolli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

N Di Muzio

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

6 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

number of pages

10

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

1270-1279

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-014-2734-6

9 March 2020

exact match

0 references

cites work

Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Management of recurrent disease after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Prostate cancer relapse after therapy with curative intention: a diagnostic and therapeutic dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

The Early Prostate Cancer program: bicalutamide in nonmetastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

[11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Salvage lymphadenectomy in postprostatectomy patients with prostate-specific antigen recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

First results of [11C]choline PET/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Should we perform imaging-guided lymph node dissection in patients with lymphatic recurrence of prostate cancer after radical prostatectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Clinical evidence on PET/CT for radiation therapy planning in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Performance evaluation of the new whole-body PET/CT scanner: Discovery ST.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Physics aspects of prostate tomotherapy: planning optimization and image-guidance issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

The natural history of noncastrate metastatic prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2734-6

Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study.

21 January 2018

1 reference

12 December 2020

The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical Prostatectomy

1 reference

12 December 2020

Efficacy of eradicative radiotherapy for limited nodal metastases detected with choline PET scan in prostate cancer patients

1 reference

12 December 2020

[11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months.

1 reference

12 December 2020

Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases

1 reference

12 December 2020

Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer

1 reference

12 December 2020

PET/CT in diagnostic oncology.

1 reference

12 December 2020

Phase I-II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer

1 reference

12 December 2020

Influence of 11C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer

1 reference

12 December 2020

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

12 December 2020

Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer

1 reference

12 December 2020

10.1007/S00259-014-2734-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24599378%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference